Abstract
Intravenous thrombolysis with recombinant tissue plasminogen activator is active treatment in ischemic stroke. Including criteria, absolute and relative contraindications and further management after application are presented.
Intravenous thrombolysis with recombinant tissue plasminogen activator is active treatment in ischemic stroke. Including criteria, absolute and relative contraindications and further management after application are presented.